Amgen (AMGN) Announces it Won Patent Case on Enbrel
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) today announced that the U.S. District Court for the District of New Jersey has ruled in Amgen's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


